Topological Pattern Recognition of Severe Alzheimer's Disease via Regularized Supervised Learning of EEG Complexity

Graph neural networks for electroencephalogram analysis: Alzheimer's disease and epilepsy use cases

Electroencephalography (EEG) is widely used as a non-invasive technique for the diagnosis of several brain disorders, including Alzheimer's disease and epilepsy. Until recently, diseases have been identified over EEG readings by human experts, which may not only be specific and difficult to find, but are also subject to human error. Despite the recent emergence of machine learning methods for the interpretation of EEGs, most approaches are not capable of capturing the underlying arbitrary non-Euclidean relations between signals in the different regions of the human brain. In this context, Graph Neural Networks (GNNs) have gained attention for their ability to effectively analyze complex relationships within different types of graph-structured data. This includes EEGs, a use case still relatively unexplored. In this paper, we aim to bridge this gap by presenting a study that applies GNNs for the EEG-based detection of Alzheimer's disease and discrimination of two different types of seizures. To this end, we demonstrate the value of GNNs by showing that a single GNN architecture can achieve state-of-the-art performance in both use cases. Through design space explorations and explainability analysis, we develop a graph-based transformer that achieves cross-validated accuracies over 89% and 96% in the ternary classification variants of Alzheimer's disease and epilepsy use cases, respectively, matching the intuitions drawn by expert neurologists. We also argue about the computational efficiency, generalizability and potential for real-time operation of GNNs for EEGs, positioning them as a valuable tool for classifying various neurological pathologies and opening up new prospects for research and clinical practice.

Contribution of Scalp Regions to Machine Learning-Based Classification of Dementia Utilizing Resting-State qEEG Signals

Purpose

This study aims to investigate using eyes-open (EO) and eyes-closed (EC) resting-state EEG data to diagnose cognitive impairment using machine learning methods, enhancing timely intervention and cost-effectiveness in dementia research.

Participants and Methods

A total of 890 participants aged 40-90 were included in the study, comprising 269 healthy controls (HC), 356 individuals with mild cognitive impairment (MCI), and 265 with Alzheimer's disease (AD) from a cohort study. Resting-state EEG (rEEG) signals were recorded and transformed into relative power spectral density (PSD) data for analysis. The processed PSD data, representing 19 scalp regions, were then input into a Random Forest (RF) machine learning classifier to identify distinctive EEG patterns across the groups. Statistical comparisons between the groups were conducted using one-way ANOVA, applied to the relative PSD features extracted from the EEG data, to assess significant differences in EEG activity across the diagnostic categories.

Results

The study found that rEEG-based categorization effectively differentiates between cognitively impaired individuals and healthy individuals. The EO rEEG achieved the highest performance metrics across various models. For HC vs MCI (combined hemisphere), the accuracy, sensitivity, specificity, and AUC were 92%, 99%, 83%, and 96%, respectively. For HC vs AD (parietal, temporal, occipital), these metrics were 95%, 96%, 94%, and 99%. The HC vs CASE (MCI + AD) (combined hemisphere) results were 90%, 99%, 73%, and 92%. The metrics for HC vs MCI vs AD (frontal, parietal, temporal) were 89%, 88%, 94%, and 96%.

Conclusion

The study demonstrates that EO rEEG can effectively distinguish between cognitive impairment and healthy states, leading to early diagnosis, cost-effective treatment, and better clinical outcomes for dementia patients. EO and EC rEEG models trained with relative PSD, particularly from parietal, temporal, occipital, and central scalp regions, can significantly assist clinicians in practice.

Towards discovery and implementation of neurophysiologic biomarkers of Alzheimer's disease using entropy methods

Alzheimer's disease (AD) is a prevalent and debilitating neurodegenerative disease that leads to substantial loss of quality of life. Therapies currently available for AD do not modify the disease course and have limited efficacy in symptom control. As such, novel and precise therapies tailored to individual patients' neurophysiologic profiles are needed. Functional neuroimaging tools have demonstrated substantial potential to provide quantifiable insight into brain function in various neurologic disorders, particularly AD. Entropy, a novel analysis for better understanding the nonlinear nature of neurophysiological data, has demonstrated consistent accuracy in disease detection. This literature review characterizes the use of entropy-based analyses from functional neuroimaging tools, including electroencephalography (EEG) and magnetoencephalography (MEG), in patients with AD for disease detection, therapeutic response measurement, and providing clinical insights.

LCADNet: a novel light CNN architecture for EEG-based Alzheimer disease detection

Alzheimer's disease (AD) is a progressive and incurable neurologi-cal disorder with a rising mortality rate, worsened by error-prone, time-intensive, and expensive clinical diagnosis methods. Automatic AD detection methods using hand-crafted Electroencephalogram (EEG) signal features lack accuracy and reliability. A lightweight convolution neural network for AD detection (LCADNet) is investigated to extract disease-specific features while reducing the detection time. The LCADNet uses two convolutional layers for extracting complex EEG features, two fully connected layers for selecting disease-specific features, and a softmax layer for predicting AD detection probability. A max-pooling layer interlaced between convolutional layers decreases the time-domain redundancy in the EEG signal. The efficiency of the LCADNet and four pre-trained models using transfer learning is compared using a publicly available AD detection dataset. The LCADNet shows the lowest computation complexity in terms of both the number of floating point operations and inference time and the highest classification performance across six measures. The generalization of the LCADNet is assessed by cross-testing it with two other publicly available AD detection datasets. It outperforms existing EEG-based AD detection methods with an accuracy of 98.50%. The LCADNet may be a valuable aid for neurologists and its Python implemen- tation can be found at github.com/SandeepSangle12/LCADNet.git.

Is EEG Entropy a Useful Measure for Alzheimer's Disease?

BACKGROUND

The number of individuals diagnosed with Alzheimer's disease (AD) has increased, and it is estimated to continue rising in the coming years. The diagnosis of this disease is challenging due to variations in onset and course, its diverse clinical manifestations, and the indications for measuring deposit biomarkers. Hence, there is a need to develop more precise and less invasive diagnostic tools. Multiple studies have considered using electroencephalography (EEG) entropy measures as an indicator of the onset and course of AD. Entropy is deemed suitable as a potential indicator based on the discovery that variations in its complexity can be associated with specific pathologies such as AD.

METHODOLOGY

Following PRISMA guidelines, a literature search was conducted in 4 scientific databases, and 40 articles were analyzed after discarding and filtering.

RESULTS

There is a diversity in entropy measures; however, Sample Entropy (SampEn) and Multiscale Entropy (MSE) are the most widely used (21/40). In general, it is found that when comparing patients with controls, patients exhibit lower entropy (20/40) in various areas. Findings of correlation with the level of cognitive decline are less consistent, and with neuropsychiatric symptoms (2/40) or treatment response less explored (2/40), although most studies show lower entropy with greater severity. Machine learning-based studies show good discrimination capacity.

CONCLUSIONS

There is significant difficulty in comparing multiple studies due to their heterogeneity; however, changes in Multiscale Entropy (MSE) scales or a decrease in entropy levels are considered useful for determining the presence of AD and measuring its severity.

Medical prediction from missing data with max-minus negative regularized dropout

Missing data is a naturally common problem faced in medical research. Imputation is a widely used technique to alleviate this problem. Unfortunately, the inherent uncertainty of imputation would make the model overfit the observed data distribution, which has a negative impact on the model generalization performance. R-Drop is a powerful technique to regularize the training of deep neural networks. However, it fails to differentiate the positive and negative samples, which prevents the model from learning robust representations. To handle this problem, we propose a novel negative regularization enhanced R-Drop scheme to boost performance and generalization ability, particularly in the context of missing data. The negative regularization enhanced R-Drop additionally forces the output distributions of positive and negative samples to be inconsistent with each other. Especially, we design a new max-minus negative sampling technique that uses the maximum in-batch values to minus the mini-batch to yield the negative samples to provide sufficient diversity for the model. We test the resulting max-minus negative regularized dropout method on three real-world medical prediction datasets, including both missing and complete cases, to show the effectiveness of the proposed method.

CNN for a Regression Machine Learning Algorithm for Predicting Cognitive Impairment Using qEEG

Purpose

Electroencephalogram (EEG) signals give detailed information on the electrical brain activities occurring in the cerebral cortex. They are used to study brain-related disorders such as mild cognitive impairment (MCI) and Alzheimer's disease (AD). Brain signals obtained using an EEG machine can be a neurophysiological biomarker for early diagnosis of dementia through quantitative EEG (qEEG) analysis. This paper proposes a machine learning methodology to detect MCI and AD from qEEG time-frequency (TF) images of the subjects in an eyes-closed resting state (ECR).

Participants and Methods

The dataset consisted of 16,910 TF images from 890 subjects: 269 healthy controls (HC), 356 MCI, and 265 AD. First, EEG signals were transformed into TF images using a Fast Fourier Transform (FFT) containing different event-rated changes of frequency sub-bands preprocessed from the EEGlab toolbox in the MATLAB R2021a environment software. The preprocessed TF images were applied in a convolutional neural network (CNN) with adjusted parameters. For classification, the computed image features were concatenated with age data and went through the feed-forward neural network (FNN).

Results

The trained models', HC vs MCI, HC vs AD, and HC vs CASE (MCI + AD), performance metrics were evaluated based on the test dataset of the subjects. The accuracy, sensitivity, and specificity were evaluated: HC vs MCI was 83%, 93%, and 73%, HC vs AD was 81%, 80%, and 83%, and HC vs CASE (MCI + AD) was 88%, 80%, and 90%, respectively.

Conclusion

The proposed models trained with TF images and age can be used to assist clinicians as a biomarker in detecting cognitively impaired subjects at an early stage in clinical sectors.

Brain entropy, fractal dimensions and predictability: A review of complexity measures for EEG in healthy and neuropsychiatric populations

There has been an increasing trend towards the use of complexity analysis in quantifying neural activity measured by electroencephalography (EEG) signals. On top of revealing complex neuronal processes of the brain that may not be possible with linear approaches, EEG complexity measures have also demonstrated their potential as biomarkers of psychopathology such as depression and schizophrenia. Unfortunately, the opacity of algorithms and descriptions originating from mathematical concepts have made it difficult to understand what complexity is and how to draw consistent conclusions when applied within psychology and neuropsychiatry research. In this review, we provide an overview and entry-level explanation of existing EEG complexity measures, which can be broadly categorized as measures of predictability and regularity. We then synthesize complexity findings across different areas of psychological science, namely, in consciousness research, mood and anxiety disorders, schizophrenia, neurodevelopmental and neurodegenerative disorders, as well as changes across the lifespan, while addressing some theoretical and methodological issues underlying the discrepancies in the data. Finally, we present important considerations when choosing and interpreting these metrics.

Travieso-González C. Analysis of Brain Computer Interface Using Deep and Machine Learning

Pattern recognition is becoming increasingly important topic in all sectors of society. From the optimization of processes in the industry to the detection and diagnosis of diseases in medicine. Brain-computer interfaces are introduced in this chapter. Systems capable of analyzing brain signal patterns, processing and interpreting them through machine and deep learning algorithms. In this chapter, a hybrid deep/machine learning ensemble system for brain pattern recognition is proposed. It is capable to recognize patterns and translate the decisions to BCI systems. For this, a public database (Physionet) with data of motor tasks and mental tasks is used. The development of this chapter consists of a brief summary of the state of the art, the presentation of the model together with some results and some promising conclusions.

Identifying Amnestic Mild Cognitive Impairment With Convolutional Neural Network Adapted to the Spectral Entropy Heat Map of the Electroencephalogram

Mild cognitive impairment (MCI) is a preclinical stage of Alzheimer's disease (AD), and early diagnosis and intervention may delay its deterioration. However, the electroencephalogram (EEG) differences between patients with amnestic mild cognitive impairment (aMCI) and healthy controls (HC) subjects are not as significant compared to those with AD. This study addresses this situation by proposing a computer-aided diagnostic method that also aims to improve model performance and assess the sensitive areas of the subject's brain. The EEG data of 46 subjects (20HC/26aMCI) were enhanced with windowed moving segmentation and transformed from 1D temporal data to 2D spectral entropy images to measure the efficient information in the time-frequency domain from the point of view of information entropy; A novel convolution module is devised, which considerably reduces the number of model learning parameters and saves computing resources on the premise of ensuring diagnostic performance; One more thing, the cognitive diagnostic contribution of the corresponding channels in each brain region was measured by the weight coefficient of the input and convolution unit. Our results showed that when the segmental window overlap rate was increased from 0 to 75%, the corresponding generalization accuracy increased from 91.673 ± 0.9578% to 94.642 ± 0.4035%; Approximately 35% reduction in model learnable parameters by optimizing the network structure while maintaining accuracy; The top four channels were FP1, F7, T5, and F4, corresponding to the frontal and temporal lobes, in descending order of the mean value of the weight coefficients. This paper proposes a novel method based on spectral entropy image and convolutional neural network (CNN), which provides a new perspective for the identifying of aMCI based on EEG.

A novel deep learning approach using AlexNet for the classification of electroencephalograms in Alzheimer's Disease and Mild Cognitive Impairment

Alzheimer's Disease (AD) is the most common form of dementia. Mild Cognitive Impairment (MCI) is the term given to the stage describing prodromal AD and represents a 'risk factor' in early-stage AD diagnosis from normal cognitive decline due to ageing. The electroencephalogram (EEG) has been studied extensively for AD characterization, but reliable early-stage diagnosis continues to present a challenge. The aim of this study was to introduce a novel way of classifying between AD patients, MCI subjects, and age-matched healthy control (HC) subjects using EEG-derived feature images and deep learning techniques. The EEG recordings of 141 age-matched subjects (52 AD, 37 MCI, 52 HC) were converted into 2D greyscale images representing the Pearson correlation coefficients and the distance Lempel-Ziv Complexity (dLZC) between the 21 EEG channels. Each feature type was computed from EEG epochs of 1s, 2s, 5s and 10s segmented from the original recording. The CNN architecture AlexNet was modified and employed for this three-way classification task and a 70/30 split was used for training and validation with each of the different epoch lengths and EEG-derived images. Whilst a maximum classification accuracy of 73.49% was obtained using dLZC-derived images from 10s epochs as input to the model, the classification accuracy reached 98.13% using the images obtained from Pearson correlation coefficients and 5s epochs. Clinical Relevance- The preliminary findings from this study show that deep learning applied to the analysis of the EEG can classify subjects with accuracies close to 100.

Spatial-temporal graph convolutional network for Alzheimer classification based on brain functional connectivity imaging of electroencephalogram

Functional connectivity of the human brain, representing statistical dependence of information flow between cortical regions, significantly contributes to the study of the intrinsic brain network and its functional mechanism. To fully explore its potential in the early diagnosis of Alzheimer's disease (AD) using electroencephalogram (EEG) recordings, this article introduces a novel dynamical spatial-temporal graph convolutional neural network (ST-GCN) for better classification performance. Different from existing studies that are based on either topological brain function characteristics or temporal features of EEG, the proposed ST-GCN considers both the adjacency matrix of functional connectivity from multiple EEG channels and corresponding dynamics of signal EEG channel simultaneously. Different from the traditional graph convolutional neural networks, the proposed ST-GCN makes full use of the constrained spatial topology of functional connectivity and the discriminative dynamic temporal information represented by the 1D convolution. We conducted extensive experiments on the clinical EEG data set of AD patients and Healthy Controls. The results demonstrate that the proposed method achieves better classification performance (92.3%) than the state-of-the-art methods. This approach can not only help diagnose AD but also better understand the effect of normal ageing on brain network characteristics before we can accurately diagnose the condition based on resting-state EEG.

A Review of Methods of Diagnosis and Complexity Analysis of Alzheimer's Disease Using EEG Signals

This study will concentrate on recent research on EEG signals for Alzheimer's diagnosis, identifying and comparing key steps of EEG-based Alzheimer's disease (AD) detection, such as EEG signal acquisition, preprocessing function extraction, and classification methods. Furthermore, highlighting general approaches, variations, and agreement in the use of EEG identified shortcomings and guidelines for multiple experimental stages ranging from demographic characteristics to outcomes monitoring for future research. Two main targets have been defined based on the article's purpose: (1) discriminative (or detection), i.e., look for differences in EEG-based features across groups, such as MCI, moderate Alzheimer's disease, extreme Alzheimer's disease, other forms of dementia, and stable normal elderly controls; and (2) progression determination, i.e., look for correlations between EEG-based features and clinical markers linked to MCI-to-AD conversion and Alzheimer's disease intensity progression. Limitations mentioned in the reviewed papers were also gathered and explored in this study, with the goal of gaining a better understanding of the problems that need to be addressed in order to advance the use of EEG in Alzheimer's disease science.

The effect of three-circle post standing (Zhanzhuang) qigong on the physical and psychological well-being of college students: A randomized controlled trial

BACKGROUND

Qigong has a long-term application by integration of mind, breath and body to prevent and cure diseases. Researches show that qigong practice could adjust anxiety, the mechanism may found on brain and heart functions. Currently there are limitations on qigong's anxiety-release mechanism study between mind and body, and existing studies lack of evidence on electrophysiology research. Our objective to analyse qigong's anxiety-release effect and mechanism.

METHODS

A two-arm randomized clinical trial with 144 qigong naïve anxiety subjects without cerebral or cardiovascular diseases or other severe syndromes will be allocated to either a body and breath regulation group (n = 72) or a body regulation group (n = 72). Participants will conduct three-circle post standing qigong exercise 5 times per week for 8 weeks, while the three-circle post standing qigong combined with abdominal breath regulation (TCPSQ-BR) group will combined with abdominal breath regulation. The primary outcome will be the Self-Rating Anxiety Scale (SAS), and the secondary outcome will be complexity-based measures of heart rate and electroencephalogram (EEG) signals assessed at baseline and 8 weeks. Multiscale entropy analysis will be used as measure of complexity.

CONCLUSION

This study will be investigate the effects of qigong's anxiety-release by SAS, and will analyze the coordinates of EEG and heart rate variability (HRV) signals before and after three-circle post standing qigong (TCPSQ) practice, and to analyse their synergies by complex signal process method.

ETHICS AND TRAIL REGISTRATION

The protocol was approved by the institutional review boards of Beijing University of Chinese Medicine (2018BZHYLL0109). This study was registered with the "Chinese Clinical Trail Registry" in the WHO Registry Network (ChiCTR-Bon-17010840).

Deep learning of resting-state electroencephalogram signals for three-class classification of Alzheimer's disease, mild cognitive impairment and healthy ageing

Objective.This study aimed to produce a novel deep learning (DL) model for the classification of subjects with Alzheimer's disease (AD), mild cognitive impairment (MCI) subjects and healthy ageing (HA) subjects using resting-state scalp electroencephalogram (EEG) signals.Approach.The raw EEG data were pre-processed to remove unwanted artefacts and sources of noise. The data were then processed with the continuous wavelet transform, using the Morse mother wavelet, to create time-frequency graphs with a wavelet coefficient scale range of 0-600. The graphs were combined into tiled topographical maps governed by the 10-20 system orientation for scalp electrodes. The application of this processing pipeline was used on a data set of resting-state EEG samples from age-matched groups of 52 AD subjects (82.3 ± 4.7 years of age), 37 MCI subjects (78.4 ± 5.1 years of age) and 52 HA subjects (79.6 ± 6.0 years of age). This resulted in the formation of a data set of 16197 topographical images. This image data set was then split into training, validation and test images and used as input to an AlexNet DL model. This model was comprised of five hidden convolutional layers and optimised for various parameters such as learning rate, learning rate schedule, optimiser, and batch size.Main results.The performance was assessed by a tenfold cross-validation strategy, which produced an average accuracy result of 98.9 ± 0.4% for the three-class classification of AD vs MCI vs HA. The results showed minimal overfitting and bias between classes, further indicating the strength of the model produced.Significance.These results provide significant improvement for this classification task compared to previous studies in this field and suggest that DL could contribute to the diagnosis of AD from EEG recordings.

A Review of Automated Techniques for Assisting the Early Detection of Alzheimer's Disease with a Focus on EEG

In this paper, we review state-of-the-art approaches that apply signal processing (SP) and machine learning (ML) to automate the detection of Alzheimer's disease (AD) and its prodromal stages. In the first part of the document, we describe the economic and social implications of the disease, traditional diagnosis techniques, and the fundaments of automated AD detection. Then, we present electroencephalography (EEG) as an appropriate alternative for the early detection of AD, owing to its reduced cost, portability, and non-invasiveness. We also describe the main time and frequency domain EEG features that are employed in AD detection. Subsequently, we examine some of the main studies of the last decade that aim to provide an automatic detection of AD and its previous stages by means of SP and ML. In these studies, brain data was acquired using multiple medical techniques such as magnetic resonance imaging, positron emission tomography, and EEG. The main aspects of each approach, namely feature extraction, classification model, validation approach, and performance metrics, are compiled and discussed. Lastly, a set of conclusions and recommendations for future research on AD automatic detection are drawn in the final section of the paper.

Digital Biomarkers for the Early Detection of Mild Cognitive Impairment: Artificial Intelligence Meets Virtual Reality

Elderly people affected by Mild Cognitive Impairment (MCI) usually report a perceived decline in cognitive functions that deeply impacts their quality of life. This subtle waning, although it cannot be diagnosable as dementia, is noted by caregivers on the basis of their relative’s behaviors. Crucially, if this condition is also not detected in time by clinicians, it can easily turn into dementia. Thus, early detection of MCI is strongly needed. Classical neuropsychological measures – underlying a categorical model of diagnosis - could be integrated with a dimensional assessment approach involving Virtual Reality (VR) and Artificial Intelligence (AI). VR can be used to create highly ecologically controlled simulations resembling the daily life contexts in which patients’ daily instrumental activities (IADL) usually take place. Clinicians can record patients’ kinematics, particularly gait, while performing IADL (Digital Biomarkers). Then, Artificial Intelligence employs Machine Learning (ML) to analyze them in combination with clinical and neuropsychological data. This integrated computational approach would enable the creation of a predictive model to identify specific patterns of cognitive and motor impairment in MCI. Therefore, this new dimensional cognitive-behavioral assessment would reveal elderly people’s neural alterations and impaired cognitive functions, typical of MCI and dementia, even in early stages for more time-sensitive interventions.

Complexity Analysis of EEG, MEG, and fMRI in Mild Cognitive Impairment and Alzheimer's Disease: A Review

Alzheimer's disease (AD) is a degenerative brain disease with a high and irreversible incidence. In recent years, because brain signals have complex nonlinear dynamics, there has been growing interest in studying complex changes in the time series of brain signals in patients with AD. We reviewed studies of complexity analyses of single-channel time series from electroencephalogram (EEG), magnetoencephalogram (MEG), and functional magnetic resonance imaging (fMRI) in AD and determined future research directions. A systematic literature search for 2000-2019 was performed in the Web of Science and PubMed databases, resulting in 126 identified studies. Compared to healthy individuals, the signals from AD patients have less complexity and more predictable oscillations, which are found mainly in the left parietal, occipital, right frontal, and temporal regions. This complexity is considered a potential biomarker for accurately responding to the functional lesion in AD. The current review helps to reveal the patterns of dysfunction in the brains of patients with AD and to investigate whether signal complexity can be used as a biomarker to accurately respond to the functional lesion in AD. We proposed further studies in the signal complexities of AD patients, including investigating the reliability of complexity algorithms and the spatial patterns of signal complexity. In conclusion, the current review helps to better understand the complexity of abnormalities in the AD brain and provide useful information for AD diagnosis.

Discrimination of Severity of Alzheimer’s Disease with Multiscale Entropy Analysis of EEG Dynamics

Multiscale entropy (MSE) was used to analyze electroencephalography (EEG) signals to differentiate patients with Alzheimer’s disease (AD) from healthy subjects. It was found that the MSE values of the EEG signals from the healthy subjects are higher than those of the AD ones at small time scale factors in the MSE algorithm, while lower than those of the AD patients at large time scale factors. Based on the finding, we applied the linear discriminant analysis (LDA) to optimize the differentiating performance by comparing the resulting weighted sum of the MSE values under some specific time scales of each subject. The EEG data from 15 healthy subjects, 69 patients with mild AD, and 15 patients with moderate to severe AD were recorded. As a result, the weighted sum values are significantly higher for the healthy than the patients with moderate to severe AD groups. The optimal testing accuracy under five specific scales is 100% based on the EEG signals acquired from the T4 electrode. The resulting weighted sum value for the mild AD group is in the middle of those for the healthy and the moderate to severe AD groups. Therefore, the MSE-based weighted sum value can potentially be an index of severity of Alzheimer’s disease.

Artificial intelligence approaches to predicting and detecting cognitive decline in older adults: A conceptual review

Preserving cognition and mental capacity is critical to aging with autonomy. Early detection of pathological cognitive decline facilitates the greatest impact of restorative or preventative treatments. Artificial Intelligence (AI) in healthcare is the use of computational algorithms that mimic human cognitive functions to analyze complex medical data. AI technologies like machine learning (ML) support the integration of biological, psychological, and social factors when approaching diagnosis, prognosis, and treatment of disease. This paper serves to acquaint clinicians and other stakeholders with the use, benefits, and limitations of AI for predicting, diagnosing, and classifying mild and major neurocognitive impairments, by providing a conceptual overview of this topic with emphasis on the features explored and AI techniques employed. We present studies that fell into six categories of features used for these purposes: (1) sociodemographics; (2) clinical and psychometric assessments; (3) neuroimaging and neurophysiology; (4) electronic health records and claims; (5) novel assessments (e.g., sensors for digital data); and (6) genomics/other omics. For each category we provide examples of AI approaches, including supervised and unsupervised ML, deep learning, and natural language processing. AI technology, still nascent in healthcare, has great potential to transform the way we diagnose and treat patients with neurocognitive disorders.

EEG Characterization of the Alzheimer's Disease Continuum by Means of Multiscale Entropies

Alzheimer's disease (AD) is a neurodegenerative disorder with high prevalence, known for its highly disabling symptoms. The aim of this study was to characterize the alterations in the irregularity and the complexity of the brain activity along the AD continuum. Both irregularity and complexity can be studied applying entropy-based measures throughout multiple temporal scales. In this regard, multiscale sample entropy (MSE) and refined multiscale spectral entropy (rMSSE) were calculated from electroencephalographic (EEG) data. Five minutes of resting-state EEG activity were recorded from 51 healthy controls, 51 mild cognitive impaired (MCI) subjects, 51 mild AD patients (AD_MIL), 50 moderate AD patients (AD_MOD), and 50 severe AD patients (AD_SEV). Our results show statistically significant differences (p-values < 0.05, FDR-corrected Kruskal-Wallis test) between the five groups at each temporal scale. Additionally, average slope values and areas under MSE and rMSSE curves revealed significant changes in complexity mainly for controls vs. MCI, MCI vs. AD_MIL and AD_MOD vs. AD_SEV comparisons (p-values < 0.05, FDR-corrected Mann-Whitney U-test). These findings indicate that MSE and rMSSE reflect the neuronal disturbances associated with the development of dementia, and may contribute to the development of new tools to track the AD progression.